Retraction Note: The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase
- PMID: 37069265
- PMCID: PMC7614786
- DOI: 10.1038/s41586-023-06048-x
Retraction Note: The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase
Retraction of
-
The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase.Nature. 2015 Jun 4;522(7554):106-110. doi: 10.1038/nature14492. Epub 2015 May 27. Nature. 2015. Retraction in: Nature. 2023 May;617(7959):208. doi: 10.1038/s41586-023-06048-x. PMID: 26017313 Free PMC article. Retracted.
Similar articles
-
The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase.Nature. 2015 Jun 4;522(7554):106-110. doi: 10.1038/nature14492. Epub 2015 May 27. Nature. 2015. Retraction in: Nature. 2023 May;617(7959):208. doi: 10.1038/s41586-023-06048-x. PMID: 26017313 Free PMC article. Retracted.
-
Dataset for the proteomic inventory and quantitative analysis of the breast cancer hypoxic secretome associated with osteotropism.Data Brief. 2015 Oct 23;5:621-5. doi: 10.1016/j.dib.2015.09.039. eCollection 2015 Dec. Data Brief. 2015. PMID: 26649326 Free PMC article.
-
Retraction Note: Lysyl oxidase is essential for hypoxia-induced metastasis.Nature. 2020 Mar;579(7799):456. doi: 10.1038/s41586-020-2112-4. Nature. 2020. PMID: 32188947
-
Lysyl Oxidase, a Targetable Secreted Molecule Involved in Cancer Metastasis.Cancer Res. 2016 Jan 15;76(2):188-92. doi: 10.1158/0008-5472.CAN-15-2306. Epub 2016 Jan 5. Cancer Res. 2016. PMID: 26732355 Review.
-
Lysyl oxidase mediates hypoxic control of metastasis.Cancer Res. 2006 Nov 1;66(21):10238-41. doi: 10.1158/0008-5472.CAN-06-3197. Cancer Res. 2006. PMID: 17079439 Review.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources